← back to search

Jessica L. Mester

The University of Texas Southwestern Medical Center · US
Area of research
Molecular Biology · Cancer Research
Research interest
Research focused on Germline and Medical genetics, with related work in Computational biology, Benignity, Consistency (knowledge bases). Notable publications include 'Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria', 'ClinGen Variant Curation Expert Panel experiences and standardized processes for disease and gene‐level specification of the ACMG/AMP guidelines for sequence variant interpretation', and 'Gene‐specific criteria for PTEN variant curation: Recommendations from the ClinGen PTEN Expert Panel'.
h-index
citations
1,224
works
7
NIH funding
primary concept
email

Recent publications

Calibration of additional computational tools expands ClinGen recommendation options for variant classification with PP3/BP4 criteria
Genetics in Medicine 2025cited by 40position: middledoi
Recommendations for risk allele evidence curation, classification, and reporting from the ClinGen Low Penetrance/Risk Allele Working Group
Genetics in Medicine 2023cited by 65position: middledoi
Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria
The American Journal of Human Genetics 2022cited by 507position: middledoi
Specifications of the ACMG/AMP variant interpretation guidelines for germline <i>TP53</i> variants
Human Mutation 2020cited by 164position: middledoi
ClinGen Variant Curation Expert Panel experiences and standardized processes for disease and gene‐level specification of the ACMG/AMP guidelines for sequence variant interpretation
Human Mutation 2018cited by 216position: middledoi
Gene‐specific criteria for <i>PTEN</i> variant curation: Recommendations from the ClinGen PTEN Expert Panel
Human Mutation 2018cited by 171position: firstdoi
Germline PARP4 mutations in patients with primary thyroid and breast cancers
Endocrine Related Cancer 2015cited by 61position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Sharon E. Plon · Baylor College of Medicine5 papers (2018–2025) · 4 papers (2018–2025)Heidi L. Rehm · Vanderbilt University Medical Center3 papers (2018–2025)Jonathan S. Berg · University of North Carolina at Chapel Hill3 papers (2018–2025)Steven M. Harrison · Broad Institute3 papers (2018–2025)Charis Eng · Cardiovascular Institute of the South3 papers (2015–2018) · 2 papers (2018–2020)Anne O’Donnell‐Luria · Broad Institute2 papers (2022–2025)Liying Zhang · Beihua University2 papers (2018–2020)Leslie G. Biesecker · University of Rochester Medical Center2 papers (2022–2025)Laura V. Milko · University of North Carolina at Chapel Hill2 papers (2018–2018) · 2 papers (2022–2025)Bing Feng · Guangzhou University of Chinese Medicine2 papers (2020–2022)Scott Topper · Directorate-General for Interpretation2 papers (2022–2025)Rachel Karchin · University of Baltimore2 papers (2022–2025)Natasha T. Strande · WinnMed2 papers (2022–2025)Madhuri Hegde · BVI (United States)2 papers (2018–2018)Kristy Lee · University of North Carolina at Chapel Hill2 papers (2018–2020)Steven E. Brenner · University of California, Berkeley2 papers (2022–2025)Predrag Radivojac · Hebrew University of Jerusalem2 papers (2022–2025)